Pharvaris BV • PHVS

Capital at risk.

About Pharvaris BV
Ticker
info
PHVS
Trading on
info
NASDAQ
ISIN
info
NL00150005Y4
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Berndt Axel Edvard Modig CPA, M.B.A.
Headquarters
info
Grafenauweg 8, Zug, undefined, Switzerland, 6300
Employees
info
114
Website
info
https://pharvaris.com
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist for the treatment of attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), as well as in Phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Metrics
BasicAdvanced
Market cap
info
$1.4B
P/E ratio
info
-
EPS
info
-$3.55
Dividend Yield
info
0.00%
Beta
info
-2.78
Forward P/E ratio
info
0
EBIDTA
info
$-166M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.4B
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
6.89
Earnings
EPS
info
-$3.55
EPS estimate (current quarter)
info
-$0.77
EPS estimate (next quarter)
info
-$0.81
EBITDA
info
$-166M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-2.78
52-week High
info
$26.33
52-week Low
info
$11.51
50-day moving average
info
$23.12
200-day moving average
info
$19.00
Short ratio
info
2.15
Short %
info
1.02%
Management effectiveness
ROE (TTM)
info
-65.09%
ROA (TTM)
info
-36.85%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
64.3M
Float
info
37.1M
Insiders %
info
5.32%
Institutions %
info
76.84%
Analyst Insights & forecasts
info

89% Buy

0% Hold

11% Sell

Based on information from 9 analysts.

Average price target

info
$36.71
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.77
-$0.59
-30.05%
Q3 • 24Missed
-$0.64
-$0.73
11.91%
Q4 • 24Beat
-$0.64
-$0.72
11.30%
Q1 • 25Beat
-$0.83
-$0.77
-7.99%
Q2 • 25Missed
-
-$0.68
100.00%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-46.3M
-∞%
Q1 • 25
$0M
$-45.5M
-∞%
Q2 • 25
NaN%
-1.86%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$248M
$22.7M
9.16%
Q1 • 25
$210M
$25.5M
12.14%
Q2 • 25
-15.42%
12.10%
32.54%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-38.5M
$-0.2M
$-0.1M
$-38.6M
Q1 • 25
$-30M
$0M
$-0M
$-30M
Q2 • 25
-22.07%
-110.33%
-69.65%
-22.44%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Pharvaris BV share?
Collapse

Pharvaris BV shares are currently traded for undefined per share.

How many shares does Pharvaris BV have?
Collapse

Pharvaris BV currently has 64.3M shares.

Does Pharvaris BV pay dividends?
Collapse

No, Pharvaris BV doesn't pay dividends.

What is Pharvaris BV 52 week high?
Collapse

Pharvaris BV 52 week high is $26.33.

What is Pharvaris BV 52 week low?
Collapse

Pharvaris BV 52 week low is $11.51.

What is the 200-day moving average of Pharvaris BV?
Collapse

Pharvaris BV 200-day moving average is $19.00.

Who is Pharvaris BV CEO?
Collapse

The CEO of Pharvaris BV is Berndt Axel Edvard Modig CPA, M.B.A..

How many employees Pharvaris BV has?
Collapse

Pharvaris BV has 114 employees.

What is the market cap of Pharvaris BV?
Collapse

The market cap of Pharvaris BV is $1.4B.

What is the P/E of Pharvaris BV?
Collapse

The current P/E of Pharvaris BV is null.

What is the EPS of Pharvaris BV?
Collapse

The EPS of Pharvaris BV is -$3.55.

What is the PEG Ratio of Pharvaris BV?
Collapse

The PEG Ratio of Pharvaris BV is null.

What do analysts say about Pharvaris BV?
Collapse

According to the analysts Pharvaris BV is considered a buy.